Advances in CRISPR/Cas systems-based cell and gene therapy

Prog Mol Biol Transl Sci. 2024:208:161-183. doi: 10.1016/bs.pmbts.2024.07.005. Epub 2024 Aug 12.

Abstract

Cell and gene therapy are innovative biomedical strategies aimed at addressing diseases at their genetic origins. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) systems have become a groundbreaking tool in cell and gene therapy, offering unprecedented precision and versatility in genome editing. This chapter explores the role of CRISPR in gene editing, tracing its historical development and discussing biomolecular formats such as plasmid, RNA, and protein-based approaches. Next, we discuss CRISPR delivery methods, including viral and non-viral vectors, followed by examining the various engineered CRISPR variants for their potential in gene therapy. Finally, we outline emerging clinical applications, highlighting the advancements in CRISPR for breakthrough medical treatments.

Keywords: CRISPR; Cas; Cell; Gene; Non-viral vector; Therapy; Viral vector.

Publication types

  • Review

MeSH terms

  • Animals
  • CRISPR-Cas Systems* / genetics
  • Cell- and Tissue-Based Therapy / methods
  • Gene Editing* / methods
  • Genetic Therapy* / methods
  • Humans